Hazlett, Burt & Watson’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-145
Closed -$15K 910
2026
Q1
$15K Buy
+145
New +$16.4K ﹤0.01% 630
2024
Q3
Sell
-12
Closed -$2K 724
2024
Q2
$2K Hold
12
﹤0.01% 651
2024
Q1
$2K Hold
12
﹤0.01% 641
2023
Q4
$2K Hold
12
﹤0.01% 614
2023
Q3
$2K Buy
+12
New +$1.82K ﹤0.01% 633
2022
Q3
Sell
-11
Closed -$2K 623
2022
Q2
$2K Hold
11
﹤0.01% 554
2022
Q1
$2K Buy
+11
New +$1.69K ﹤0.01% 556

Other funds holding CLX

Hazlett, Burt & Watson's CLX Position: Q2 2026 in Review

Hazlett, Burt & Watson sold out of Clorox (CLX) in Q2 2026, closing a stake of 145 shares — an estimated $15K sold.

Hazlett, Burt & Watson first reported a position in CLX in Q1 2022 and held it in 7 quarters. The position peaked at $15K in Q1 2026. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Hazlett, Burt & Watson reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
  • Hazlett, Burt & Watson sold 145 Clorox shares in Q2 2026, an estimated $15K.
  • Hazlett, Burt & Watson first reported a position in Clorox in Q1 2022 and held it in 7 quarters.
  • Hazlett, Burt & Watson's Clorox position peaked at $15K in Q1 2026.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.